Researchers



Results 1-20 of 135
Issue DateTitleAuthor(s)TypeМp-cat.
2026The design of multi-target ligands and their role in schizophrenia therapy: an updateGagić, Žarko ; Popović-Nikolić, Marija  ; Čarapić, Marija ; Zukić, Selma; Oljačić, Slavica  ; Nikolić, Katarina  Article
21aM21a
2026Current Computational Approaches for the Discovery of Novel Anticancer Agents Targeting VEGFR and SIRT Signaling PathwaysIlić, Aleksandra  ; Zukić, Selma; Oljačić, Slavica  ; Maran, Uko; Nikolić, Katarina  ; Popović-Nikolić, Marija  Article
21aM21a
2025First Reported QSAR Models Of Dual HDAC6 And ROCK2 Inhibitors Employing Random Forest Regression AlgorithmZukić, Selma; Beljkaš, Milan  ; Maran, Uko; Petković, Miloš  ; Nikolić, Katarina  ; Oljačić, Slavica  Conference Paper
Mp. category will be shown later
2025Consideration of electrophoretic behavior of some imidazoline and α adrenergic receptors ligands using DFT approachČebzan, Alen  ; Popović-Nikolić, Marija  ; Oljačić, Slavica  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2025Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agentsBeljkaš, Milan  ; Ružić, Dušan  ; Djurić, Ana  ; Vuletić, Ana  ; Nchugoua Tchiehe, Guilaine; Jallet, Corinne; Cadet-Daniel, Veronique; Arimondo, Paola B; Santibanez, Juan F.  ; Srdić-Rajić, Tatjana  ;
Nikolić, Katarina  ; Oljačić, Slavica  ; Petković, Miloš  ;
Article
22M22
2025Discovery of (3-Phenylcarbamoyl-3,4-dihydro-2H-pyrrol-2-yl)phosphonates as Imidazoline I2 Receptor Ligands with Anti-Alzheimer and Analgesic PropertiesBagán, Andrea; López-Ruiz, Alba; Abás, Sònia; Ruiz-Cantero, Carmen M.; Vasilopoulou, Foteini; Taboada-Jara, Teresa; Griñán-Ferré, Christian; Pallàs, Mercè; Muguruza, Carolina; Diez-Alarcia, , Rebeca;
Callado, Luis F.; Entrena, José M.; Cobos, Enrique J.; Pérez, Belén; Morales-García, José A.; Molins, Elies; De Jonghe, Steven; Daelemans, Dirk; Brea, José; Val, C.; Loza, M. Isabel; Hernández-Hernández, Elena; García-Sevilla, Jesús A.; García-Fuster, M. Julia; Díaz, Caridad; Fernández-Godino, Rosario; Genilloud, Olga; Beljkaš, Milan  ; Oljačić, Slavica  ; Nikolić, Katarina  ; Escolano, Carmen;
Article
21a+M21a+
2025Protolytic Equilibria of Cetirizine in the Presence of Micelle-Forming SurfactantsPopović-Nikolić, Marija  ; Popović, Gordana  ; Oljačić, Slavica  ; Nikolić, Katarina  Article
22M22
2025Application of Separation Methods in Biomimetic Studies and the Determination of Physicochemical Properties of Imidazoline and αAdrenergic Receptor LigandsOljacic, Slavica  ; Popovic-Nikolic, Marija  ; Obradović, Darija  ; Ruzic, Dusan; Vucicevic, Jelica; Mitja Krizman; Irena Vovk; Popovic, Gordana  ; Nikolic, Katarina  Conference Paper
Mp. category will be shown later
2025P 01 Identification of Dual-Acting HDAC Inhibitors for Pancreatic Cancer Treatment through Drug Synergy Predictions and Molecular ModelingĐoković, Nemanja  ; Ilić, Aleksandra  ; Čebzan, Alen  ; Radović, Branko  ; Ružić, Dušan  ; Beljkaš, Milan  ; Đurić, Ana  ; Srdić-Rajić, Tatjana  ; Oljačić, Slavica  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2025A linear solvation energy relationship analysis of selected imidazoline derivatives in reversed-phase thin-layer chromatographyOljačić, Slavica  ; Popović-Nikolić, Marija  ; Nikolić, Katarina  Article
23M23
2025Application of machine learning and molecular docking to the modelling and design of HDAC6/ROCK dual inhibitors with in vitro experimental validationBeljkaš, Milan  ; Zukić, Selma; Maran, Uko; Arimondo, Paola B; Petković, Miloš  ; Oljačić, Slavica  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2025Exploring the effect of bioenvironment on the ionization of drugs using the membrane mimetic properties of differently charged micellesPopović-Nikolić, Marija  ; Popović, Gordana  ; Oljačić, Slavica  ; Nikolić, Katarina  ; Agbaba, Danica Conference Paper
Mp. category will be shown later
2025Computer-Aided Drug Design of novel dual histone deacetylase inhibitorsIlić, Aleksandra  ; Beljkaš, Milan  ; Čebzan, Alen  ; Radović, Branko  ; Đoković, Nemanja  ; Nikolić, Katarina  ; Oljačić, Slavica  Conference Paper
Mp. category will be shown later
2024Modelling of chromatographic and electrophoretic behaviour of imidazoline and alpha adrenergic receptors ligands under different acid-base conditionsOljačić, Slavica  ; Križman, Mitja; Popović-Nikolić, Marija  ; Vovk, Irena; Nikolić, Katarina  ; Agbaba, Danica Article
21M21
2024Application of membrane mimetic systems approach in investigation of ionizable drugs: a case of cetirizinePopović-Nikolić, Marija  ; Oljačić, Slavica  ; Popović, Gordana  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2024Strengthening the epigenetic and signaling axis: Dual HDAC/ROCK inhibitors as a new therapeutic strategy in cancer treatmentBeljkaš, Milan  ; Petković, Miloš  ; Ružić, Dušan  ; Oljačić, Slavica  ; Nikolić, Katarina  ; Arimondo, Paola B; Srdić-Rajić, Tatjana  ; Vuletić, Ana  ; Jelić Mariokov Đurić, Ana  Conference Paper
Mp. category will be shown later
2024The effect of nonionic Brij 35 micelles on the ionization of some drugs used in the treatment of alergic reactionsPopović-Nikolić, Marija  ; Oljačić, Slavica  ; Popović, Gordana  Conference Paper
Mp. category will be shown later
2024Human papillomaviruses and cervical cancer from the perspective of the World Health Organisation initiative for cervical cancer eliminationFilipić, Brankica  ; Rapajić-Moran, Ivana; Nikolić, Ines  ; Oljačić, Slavica  ; Mandić, Aljoša  Article
51M51
2024Discovery of dual-acting HDAC inhibitors for the treatment of pancreatic cancer by combining drug synergy and molecular modelingĐoković, Nemanja  ; Ilić, Aleksandra  ; Čebzan, Alen  ; Radović, Branko  ; Ružić, Dušan  ; Beljkaš, Milan  ; Đurić, Ana  ; Srdić-Rajić, Tatjana  ; Oljačić, Slavica  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2024Evaluation of novel compounds as anti-bacterial or anti-virulence agentsFilipić, Brankica  ; Ušjak, Dušan  ; Hrast Rambaher, Martina; Oljačić, Slavica  ; Milenković, Marina  Article
21M21